Issued Feb. 19 by the U.S. Patent and Trademark Office

U.S. Class: 435-6Patent Number: 4,994,368Assignee: Syntex (U.S.A.)Claims/description: 68 claims for a method of multiplying apolynucleotide sequence.

U.S. Class: 435-6Patent Number: 4,994,369Assignee: Stanford UniversityClaims/description: 1 claim for a method of determiningwhether a T cell is stimulated or unstimulated.

U.S. Class: 435-6Patent Number: 4,994,370Assignee: Department of Health and Human ServicesClaims/description: 16 claims for a method of amplifyingdouble-stranded DNA sequences.

U.S. Class: 435-6Patent Number: 4,994,371Assignee: Earl W. Davie and Kotoku Kurachi of WashingtonStateClaims/description: 23 claims for a DNA sequence for a humanblood-clotting factor, factor IX.

U.S. Class: 435-6Patent Number: 4,994,372Assignee: Harvard CollegeClaims/description: 44 claims for a method for sequencing aDNA molecule.

U.S. Class: 435-6Patent Number: 4,994,373Assignee: Enzo Biochem Inc.Claims/description: 27 claims for a method for detecting apolynucleotide sequence.

U.S. Class: 435-69.1Patent Number: 4,994,379Assignee: Cetus Corp.Claims/description: 13 claims for a DNA sequence encoding amodified exo-signal peptide.

U.S. Class: 435-69.1Patent Number: 4,994,380Assignee: Shigezo Udaka of JapanClaims/description: 9 claims for a process for expressing genesin Bacillus brevis.

U.S. Class: 530-399Patent Number: 4,994,559Assignee: Synergen Inc.Claims/description: 1 claim for a human basic fibroblast growthfactor.

U.S. Class: 536-27Patent Number: 4,994,565Assignee: Tohoku University, JapanClaims/description: 5 claims for the DNA sequence of a genespecifically expressed by insulinoma tumor cells.

(c) 1997 American Health Consultants. All rights reserved.